Ben Ghanem A, Pallu S, Winchenne J J, Raymonjean N, Mayeux P, Goossens D, Boffa G A, Casadevall N, Cartron J P, Lambin P
Institut National de Transfusion Sanguine, Paris, France.
Hybridoma. 1993 Oct;12(5):599-608. doi: 10.1089/hyb.1993.12.599.
Several monoclonal antibodies (Mabs) against human erythropoietin (H-EPO) were obtained by fusion of myeloma cells with splenocytes from mice immunized with purified recombinant H-EPO. Three Mabs (D7, E14 and E73) were selected by radioimmunoprecipitation on the basis of their high affinity against H-EPO. Their dissociation constants were 0.3 nM for E14 and D7, and 17 nM for E73. The immunochemical properties of these Mabs were analyzed in respect to their capacity to react, to purify, and to inhibit the biological activities of H-EPO. a) detection by Western blotting techniques: among the 3 Mabs only D7 was effective by this technique. b) purification: the best results were observed with E14, an approximately 200-fold purification of H-EPO from culture supernatants was obtained in a single immunopurification step. c) inhibition of the biological activity: the specific binding of 125I-labelled H-EPO to its cellular receptor was inhibited by E14 and E73 but not by D7. These three Mabs exhibited similar effects as far as the inhibition of the proliferation of H-EPO dependent cells (measured by 3H-thymidine incorporation) was concerned.
通过将骨髓瘤细胞与用纯化的重组人促红细胞生成素(H-EPO)免疫的小鼠脾细胞融合,获得了几种抗人促红细胞生成素(H-EPO)的单克隆抗体(Mabs)。基于它们对H-EPO的高亲和力,通过放射免疫沉淀法筛选出三种单克隆抗体(D7、E14和E73)。E14和D7的解离常数为0.3 nM,E73的解离常数为17 nM。对这些单克隆抗体的免疫化学特性进行了分析,涉及它们与H-EPO反应、纯化以及抑制其生物活性的能力。a)通过蛋白质印迹技术检测:在这三种单克隆抗体中,只有D7通过该技术有效。b)纯化:使用E14观察到了最佳结果,在单次免疫纯化步骤中,从培养上清液中获得了约200倍的H-EPO纯化。c)生物活性抑制:E14和E73抑制了125I标记的H-EPO与其细胞受体的特异性结合,但D7没有。就抑制H-EPO依赖性细胞的增殖(通过3H-胸腺嘧啶核苷掺入法测量)而言,这三种单克隆抗体表现出相似的效果。